Diabetes Treatment and Management
Most cited papers
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine · 1993 · 24,828 citations
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine · 2002 · 19,308 citations
- International Diabetes Federation 2017Journal of Diabetes · 2018 · 13,379 citations
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 DiabetesNew England Journal of Medicine · 2015 · 12,596 citations
- Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose ToleranceNew England Journal of Medicine · 2001 · 10,955 citations
- Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyBMJ · 2000 · 9,235 citations
- Canagliflozin and Cardiovascular and Renal Events in Type 2 DiabetesNew England Journal of Medicine · 2017 · 8,032 citations
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine · 2008 · 7,947 citations
- Liraglutide and Cardiovascular Outcomes in Type 2 DiabetesNew England Journal of Medicine · 2016 · 7,900 citations
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesNew England Journal of Medicine · 2008 · 7,848 citations
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionNew England Journal of Medicine · 2019 · 7,529 citations
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine · 2008 · 7,462 citations
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine · 2016 · 7,190 citations
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine · 1998 · 7,026 citations
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38BMJ · 1998 · 6,715 citations
- Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesNew England Journal of Medicine · 2018 · 6,600 citations
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and NephropathyNew England Journal of Medicine · 2019 · 6,422 citations
- Dapagliflozin in Patients with Chronic Kidney DiseaseNew England Journal of Medicine · 2020 · 5,992 citations
- Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic RatsCellular Physiology and Biochemistry · 2015 · 5,952 citations
- Once-Weekly Semaglutide in Adults with Overweight or ObesityNew England Journal of Medicine · 2021 · 5,804 citations
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart FailureNew England Journal of Medicine · 2020 · 5,468 citations
- Empagliflozin in Heart Failure with a Preserved Ejection FractionNew England Journal of Medicine · 2021 · 5,211 citations
- Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 DiabetesNew England Journal of Medicine · 2005 · 5,186 citations
- 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022Diabetes Care · 2021 · 5,070 citations
- Inflammation and insulin resistanceJournal of Clinical Investigation · 2006 · 4,904 citations
- Glucose Control and Vascular Complications in Veterans with Type 2 DiabetesNew England Journal of Medicine · 2008 · 4,787 citations
- Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular CausesNew England Journal of Medicine · 2007 · 4,704 citations
- Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 DiabetesNew England Journal of Medicine · 2003 · 4,393 citations
- Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes StudyDiabetes Care · 1997 · 4,342 citations
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in RangeDiabetes Care · 2019 · 4,292 citations
- Tirzepatide Once Weekly for the Treatment of ObesityNew England Journal of Medicine · 2022 · 4,280 citations
- Bariatric Surgery versus Conventional Medical Therapy for Type 2 DiabetesNew England Journal of Medicine · 2012 · 1,802 citations
- Beneficial Effects of High Dietary Fiber Intake in Patients with Type 2 Diabetes MellitusNew England Journal of Medicine · 2000 · 1,146 citations
- Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1Proceedings of the National Academy of Sciences · 2007 · 1,015 citations
- n–3 Fatty Acids and Cardiovascular Outcomes in Patients with DysglycemiaNew England Journal of Medicine · 2012 · 937 citations
- T1R3 and gustducin in gut sense sugars to regulate expression of Na + -glucose cotransporter 1Proceedings of the National Academy of Sciences · 2007 · 904 citations
Metadata from OpenAlex (CC0).